Reduced-dose anti-thymocyte globulin combined with post-transplant cyclophosphamide versus standard ATG for graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation: a focus on chronic GVHD reduction.
Saved in:
| Title: | Reduced-dose anti-thymocyte globulin combined with post-transplant cyclophosphamide versus standard ATG for graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation: a focus on chronic GVHD reduction. |
|---|---|
| Authors: | Guo W; Department of Hematology, Luoyang Central Hospital, Zhengzhou University, Luoyang City, China., Li B; Department of Hematology, Luoyang Central Hospital, Zhengzhou University, Luoyang City, China., Tang L; Department of Hematology, Luoyang Central Hospital, Zhengzhou University, Luoyang City, China., Peng L; Department of Hematology, Luoyang Central Hospital, Zhengzhou University, Luoyang City, China., Guo S; Department of Hematology, Luoyang Central Hospital, Zhengzhou University, Luoyang City, China. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 May; Vol. 67 (6), pp. 1385-1395. Date of Electronic Publication: 2026 Mar 24. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
